Get the Stockscreener App
3.29
5.45%
0.17
After Hours:
3.40
0.11
+3.34%
Cardlytics Inc stock is traded at $3.29, with a volume of 737.17K.
It is up +5.45% in the last 24 hours and down -5.73% over the past month.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
See More
Previous Close:
$3.12
Open:
$3.17
24h Volume:
737.17K
Relative Volume:
0.83
Market Cap:
$167.21M
Revenue:
$293.47M
Net Income/Loss:
$-274.55M
P/E Ratio:
-0.5231
EPS:
-6.29
Net Cash Flow:
$-27.43M
1W Performance:
+7.69%
1M Performance:
-5.73%
6M Performance:
-55.05%
1Y Performance:
-50.15%
1-Day Range:
$3.15
$3.4401
1-Week Range:
$2.86
$3.4401
52-Week Range:
$2.763
$20.52
Cardlytics Inc Stock (CDLX) Company Profile
Name
Cardlytics Inc
Sector
Industry
Phone
888-798-5802
Address
675 PONCE DE LEON AVENUE, NE, ATLANTA, GA
Compare CDLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDLX
Cardlytics Inc
|
3.29 | 167.21M | 293.47M | -274.55M | -27.43M | -6.29 |
|
OMC
Omnicom Group Inc
|
84.23 | 16.55B | 15.43B | 1.37B | 1.50B | 7.32 |
|
WPP
Wpp Plc Adr
|
48.77 | 10.52B | 18.59B | 256.66M | 1.13B | 1.1736 |
|
IPG
Interpublic Group Of Cos Inc
|
27.72 | 9.95B | 10.86B | 808.20M | 922.50M | 2.12 |
|
MGNI
Magnite Inc
|
19.14 | 2.69B | 661.13M | 17.29M | 156.88M | 0.06 |
|
CRTO
Criteo S A Adr
|
45.89 | 2.49B | 1.96B | 102.18M | 144.20M | 1.72 |
Cardlytics Inc Stock (CDLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-11-24 | Initiated | Evercore ISI | In-line |
| Aug-16-24 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-15-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-08-24 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-08-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-08-24 | Downgrade | Needham | Buy → Hold |
| Jun-20-24 | Resumed | BofA Securities | Neutral |
| Jun-18-24 | Initiated | Northland Capital | Outperform |
| Mar-15-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-29-23 | Initiated | Lake Street | Buy |
| Sep-08-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-14-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-12-22 | Downgrade | Craig Hallum | Buy → Hold |
| Apr-05-22 | Resumed | Wells Fargo | Overweight |
| Jun-18-21 | Initiated | Needham | Buy |
| Apr-15-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-14-21 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-05-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-28-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-21-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Mar-04-20 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-15-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-02-19 | Initiated | Craig Hallum | Buy |
| Nov-14-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-09-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-24-19 | Reiterated | BofA/Merrill | Buy |
| Jul-01-19 | Initiated | William Blair | Outperform |
| Jan-15-19 | Upgrade | BofA/Merrill | Neutral → Buy |
View All
Cardlytics Inc Stock (CDLX) Latest News
CDLX Investors Have Opportunity to Lead Cardlytics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Class Action Filed Against Cardlytics, Inc. (CDLX) - GlobeNewswire Inc.
Adversity is less terrifying than hope: Cardlytics Inc (CDLX) - SETE News
Investors in Cardlytics, Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your RightsCDLX - PR Newswire
Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman - GlobeNewswire
Did Cardlytics Inc (CDLX) perform well in the last session? - US Post News
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - yourbigsky.com
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
The Potential Rise in the Price of Cardlytics Inc (CDLX) following insiders activity - Knox Daily
CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics - GlobeNewswire
IMPORTANT NOTICE: IF YOUR FINANCIAL ADVISOR RECOMMENDED CARDLYTICS, INC. INVESTMENTS PLEASE CONTACT KT LAW - EIN News
CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - yourbigsky.com
Shareholders that lost money on Cardlytics, Inc.(CDLX) Urged to - GuruFocus.com
Shareholders that lost money on Cardlytics, Inc.(CDLX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - Marketscreener.com
Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) Insider Sells 3,377 Shares of Stock - MarketBeat
Cardlytics, Inc. Stock Alert: Robbins LLP Reminds Investors of the Class Action Against CDLX - GlobeNewswire
CARDLYTICS, INC. (NASDAQ: CDLX) INVESTOR ALERT: Investors - GlobeNewswire
CARDLYTICS, INC. (NASDAQ: CDLX) INVESTOR ALERT: Investors With Large Losses in Cardlytics, Inc. Should Contact - EIN News
Cardlytics, Inc. Sued for Securities Law ViolationsContact Th - GuruFocus.com
Cardlytics, Inc. (NASDAQ:CDLX) Receives $6.92 Consensus Price Target from Analysts - MarketBeat
CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Cardlytics, Inc. Class Action Alert: Wolf Haldenstein Adler - GlobeNewswire
CDLX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Indo-Asian News Service - IANS India Pvt Ltd
CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics - GlobeNewswire
CARDLYTICS ALERT: Bragar Eagel & Squire, P.C. Announces - GlobeNewswire
Shareholder Notice: Robbins LLP Informs Stockholders of the Cardlytics, Inc. Class Action - Finansavisen
CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Great week for Cardlytics, Inc. (NASDAQ:CDLX) institutional investors after losing 46% over the previous year - Simply Wall St
Advertising Platform's Changes Hurt Investors, Suit Says - Law360
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
2025-01-27 | CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:CDLX | Press Release - Stockhouse Publishing
Rosen Law Firm Urges Cardlytics, Inc. (NASDAQ: CDLX) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics - Markets Insider
Cardlytics CEO Amit Gupta sells common stock for $59,427 - MSN
Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells 15,160 Shares of Stock - MarketBeat
Cardlytics CEO Amit Gupta sells common stock for $59,427 By Investing.com - Investing.com Canada
Major Stock Plunge Alert! Are You Affected? - Mi Valle
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics - Business Wire
Cardlytics Inc Stock (CDLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):